💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Karyopharm Therapeutics Inc. (KPTI)
« Back to company indexKPTI Chatter Timeline
Stock Ticker for KPTI
Most Active Tweeters for KPTI
| User | Tweets |
|---|---|
| @DueDoctor | 17 |
| @Tickeron | 15 |
| @FlashAlert_me | 13 |
| @InsiderAlerts4U | 6 |
| @StocksoftheDay_ | 6 |
Recent Tweets for KPTI
 |
@alerts_real $KPTI ?Top analyst price target today? ? https://t.co/CGNu8CQAXp May 28th 2022, 1:05pm |
 |
@StocksoftheDay_ $KPTI News Screener Alert: The price is up after the recent publication posted about 20 hours ago .… https://t.co/Fqmgc43yUL May 27th 2022, 5:05pm |
 |
@ResearchPool $KPTI #Karyopharm Therapeutics Selinexors DisCOMFORTing Comparisons: [...] https://t.co/pp36mURHuR #equity #stocks https://t.co/My54jhlYQ9 May 27th 2022, 11:05am |
 |
@Tickeron $KPTI in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/JyHt1gpqC8 May 27th 2022, 10:05am |
 |
@WatcherBiotech $KPTI This MF data has to be a positive surprise https://t.co/W0XcGOoSLe May 27th 2022, 8:05am |
 |
@1stOncology #Karyopharm to Present New #Selinexor Data at the #ASCO22 $KPTI https://t.co/Plq2LcT4zh May 27th 2022, 7:05am |
 |
@Biotech2050 RT @DueDoctor: https://t.co/74HvuPHnHE $KPTI Selinexor gains Orphan Drug Status for Myelofibrosis Not huge news but pretty great timing.… May 27th 2022, 4:05am |
|
@Biotech2050 RT @Karyopharm: Karyopharm $KPTI to Present New Data at the 2022 American Society of Clinical Oncology Annual Meeting #ASCO22 Learn More… May 27th 2022, 4:05am |
 |
@DueDoctor https://t.co/74HvuPHnHE $KPTI Selinexor gains Orphan Drug Status for Myelofibrosis Not huge news but pretty great… https://t.co/B5pb7qGJ8r May 27th 2022, 4:05am |
|
@Tickeron $KPTI enters an Uptrend because Momentum Indicator exceeded the 0 level on May 25, 2022. View odds for this and oth… https://t.co/d4VC3ndWZT May 27th 2022, 2:05am |
|
@Tickeron Is this good for your portfolio? $KPTI Stochastic Oscillator left the overbought zone. #KaryopharmTherapeutics… https://t.co/STzh46VkmW May 27th 2022, 1:05am |
|
@Tickeron How does this make you feel? $KPTI entered Uptrend as Momentum indicator ascends above 0 level.… https://t.co/TxVFV0Ibi2 May 27th 2022, 12:05am |
 |
@MarcJacksonLA $KPTI Karyopharm to Present New Selinexor Data at the 2022 American Society of Clinical Oncology Annual Meeting https://t.co/1HlDIj99UE May 26th 2022, 10:05pm |
 |
@Karyopharm Karyopharm $KPTI to Present New Data at the 2022 American Society of Clinical Oncology Annual Meeting #ASCO22 Lea… https://t.co/Zx77jvjCBP May 26th 2022, 9:05pm |
 |
@StockNewsBot2 $KPTI Karyopharm to Present New Selinexor Data at the 2022 American Society of Clinical Oncology Annual Meeting https://t.co/SVKqgqZAYc May 26th 2022, 9:05pm |
 |
@newsfilterio Karyopharm to Present New Selinexor Data at the 2022 American Society of Clinical Oncology Annual Meeting $KPTI https://t.co/MDEgrXglx9 May 26th 2022, 9:05pm |
 |
@FastestAlert $KPTI Karyopharm To Present New Selinexor Data At The 2022 American Society Of Clinical Oncology Annual Meeting Stock News Alerts In Bio May 26th 2022, 9:05pm |
 |
@stock_titan $KPTI Karyopharm to Present New Selinexor Data at the 2022 American Society of Clinical Oncology Annual Meeting https://t.co/x5Iv0aTL9C May 26th 2022, 9:05pm |
|
@MarcJacksonLA $KPTI The European Myeloma Network and Karyopharm Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-… https://t.co/F98mb0fWGG May 26th 2022, 7:05pm |
 |
@thudderwicks $KPTI wins FDA’s Orphan Drug status for leading asset in myelofibrosis https://t.co/pdYAIwc2HI May 26th 2022, 6:05pm |
 |
@THEHOOKUP15 Karyopharm wins FDA’s Orphan Drug status for leading asset in myelofibrosis #fdaapproval #fda #stocks #news $kpti https://t.co/fzykDz37wE May 26th 2022, 5:05pm |
 |
@MarketCurrents $KPTI - Karyopharm wins FDA’s Orphan Drug status for leading asset in myelofibrosis https://t.co/rnWgUZSBaD May 26th 2022, 5:05pm |
|
@Tickeron $KPTI's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/NaRXTPiCNO May 26th 2022, 2:05am |
 |
@ShogunTrade $KPTI Stock Trading Ideas | Awaiting Buy Signal. Start Free Trial at https://t.co/6vnULU2sSf https://t.co/WSZOyTDZAZ May 25th 2022, 2:05pm |
|
@Karyopharm The European Myeloma Network and Karyopharm $KPTI Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-… https://t.co/cPgMI0OmSI May 25th 2022, 1:05pm |
 |
@StockTraderHub $KPTI - The European Myeloma Network and Karyopharm Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-031 Study May 25th 2022, 1:05pm |
 |
@Briefingcom $KPTI: Karyopharm Therapeutics: The European Myeloma Network and Karyopharm Announce Dosing of First Patient in... https://t.co/kaLZ4rjJ70 May 25th 2022, 1:05pm |
|
@MarketCurrents $KPTI $BMY - Karyopharm begins dosing in late-stage study of selinexor combo therapy for multiple myeloma https://t.co/QreTTd2IBu May 25th 2022, 12:05pm |
|
@StocksoftheDay_ $KPTI News Screener Alert: The price is down after the recent publication posted about 1 hour ago .… https://t.co/R8o3Sub7Wy May 25th 2022, 12:05pm |
|
@thudderwicks $KPTI Phase 3 study evaluating an all oral regimen of selinexor in combination with pomalidomide and low-dose dexam… https://t.co/B8HpP21LfV May 25th 2022, 11:05am |
|
@thudderwicks $KPTI doses first patient in EMN29/XPORT-MM-031 study https://t.co/c7vDkc6DLn May 25th 2022, 11:05am |
|
@FastestAlert $KPTI The European Myeloma Network And Karyopharm Announce Dosing Of First Patient In Collaborative EMN29/XPORT-MM-… https://t.co/Vp3JCzvEiT May 25th 2022, 11:05am |
|
@StockNewsBot2 $KPTI The European Myeloma Network and Karyopharm Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-… https://t.co/n97X5PcgrO May 25th 2022, 11:05am |
|
@stock_titan $KPTI The European Myeloma Network and Karyopharm Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-… https://t.co/OvfSXWPMOA May 25th 2022, 11:05am |
 |
@WebChronicleTo1 $KPTI The European Myeloma Network and Karyopharm Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-… https://t.co/ovzHRrbeok May 25th 2022, 11:05am |
 |
@BestoTrading $KPTI Awaiting Buy Signal, chart by UltraAlgo. Get started for free at https://t.co/mOw8pmbZto https://t.co/KWaonU3Xb8 May 24th 2022, 3:05pm |
|
@StocksoftheDay_ $KPTI News Screener Alert: The price is up after the recent publication posted about 18 hours ago .… https://t.co/AGzd7TCZvU May 23rd 2022, 8:05pm |
 |
@investor_feed $KPTI 8-K Karyopharm Therapeutics (23 May, 4:06pm) ? Departure of Directors or Certain Officers; Election of D… https://t.co/nN7o9YVuuT May 23rd 2022, 8:05pm |
 |
@FlashAlert_me $KPTI [15s. delayed] filed form 8-K on May 23, 16:06:16 https://t.co/7yWHD4g5EC May 23rd 2022, 8:05pm |
 |
@_Jamison_Gaddy $KPTI close over $6 and could see a short term rally May 23rd 2022, 5:05pm |
|
@ShogunTrade $KPTI Stock Trading Ideas | Awaiting Buy Signal. Learn more at https://t.co/6vnULU2sSf https://t.co/2AtauWV6xM May 23rd 2022, 2:05pm |
|
@Tickeron $KPTI in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators:… https://t.co/B7zS2VgNlL May 23rd 2022, 12:05pm |
|
@FlashAlert_me $KPTI [15s. delayed]: Issued Press Release on May 22, 22:00:00: Antengene Announces First Patient Dosed in the Phas… https://t.co/deO67LsHKY May 23rd 2022, 2:05am |
 |
@Shingpeng1 $KPTI Top analyst price target for the next week https://t.co/BLSaZMx6ze May 22nd 2022, 10:05am |
|
@DueDoctor @awisejester I've written a lot on $KPTI, most of it is on r/KPTI. Godspeed! Dr. DD https://t.co/iC8R6oSZd6 May 22nd 2022, 12:05am |
|
@DueDoctor So for those of you asking, yes, I'm riding, and when $KPTI gets bought out in the next 9-18 months, I expect at le… https://t.co/SSwybntCdw May 21st 2022, 11:05pm |
|
@DueDoctor With + EU 2nd Line CHMP Opinion, EC approval for $KPTI in 60 days, now we wait to see if the company decided for CV… https://t.co/A2LlRuBzwV May 21st 2022, 11:05pm |
|
@DueDoctor + Buyout $KPTI signal - Compensation switched to options... for every single person on the board - check the SEC Fo… https://t.co/UEhVwHipZ8 May 21st 2022, 11:05pm |
 |
@InsiderAlerts4U $KPTI: New Insider Filing on Karyopharm Therapeutics Inc.'s Director CHRISTY J. OLIGER: https://t.co/XWCzRlzB5S May 21st 2022, 12:05pm |
|
@Tickeron $KPTI was the market's top weekly gainer, with a +8.99% jump #KaryopharmTherapeutics #stockmarket #stock https://t.co/zFwofom3y6 May 21st 2022, 11:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.